GGeroScience4/11/2026

Peripheral microRNA signature in genetic frontotemporal dementia—findings from the GENFI initiative

Chiara Fenoglio·María Serpente·Marina Arcaro·Tiziana Carandini·Luca Sacchi·Manuela Pintus·Vittoria Borracci·Giulia Giudici·Marta Rigoni·Paola Muti·Laura Ghezzi·Arabella Bouzigues·Lucy L. Rusell·Phoebe H. Foster·Eve Ferry-Bolder·John C. van Swieten·Lize C. Jiskoot·Harro Seelaar·Raquel Sánchez Valle·Robert Laforce·Caroline Graff·Rik Vandenberghe·Alexandre de Mendonça·Pietro Tiraboschi·Isabel Santana·Alexander Gerhard·Johannes Levin·Florence Pasquier·Simon Ducharme·Isabelle Le Ber·Elizabeth Finger·Maria Carmela Tartaglia·Mario Masellis·James B. Rowe·Matthis Synofzik·Fermin Moreno·Barbara Borroni·Andrea Sacconi·Jonathan D. Rohrer·Andrea Arighi·Daniela Galimberti·GENetic Frontotemporal dementia Initiative (GENFI)·Antonella Alberici·Sónia Afonso·Patricia Alves·Sarah Anderl-Straub·Anna Antonelli·Mircea Balasa·Myriam Barandiaran·Núria Bargalló·Robert Bartha·Benjamin Bender·Alexander Bernhardt·Maxime Bertoux·Anne Bertrand·Valentina Bessi·Sandra Black·Giorgio Bocca·Martina Bocchetta·Sergi Borrego-Écija·Alexis Brice·Rose Bruffaerts·Valentina Cantoni·Paola Caroppo·David Cash·Miguel Castelo-Branco·Olivier Colliot·Rhian Convery·Thomas Cope·Tiago Costa-Coelho·Ioana Croitoru·Agnès Camuzat·Liset de Boer·Julie de Houwer·Vincent Deramecourt·João Durães·Giuseppe Di Fede·Camilla Ferrari·Graziana Florio·Marta Frascotti·Morris Freedman·Aurélie Funkiewiez·Alazne Gabilondo·Roberto Gasparotti·Giorgio Giaccone·Lucia Giannini·Sophie Goldsmith·Lisa Graf·Vesna Jelic·Ron Keren·Johanna Krüger·Gregory Kuchcinski·Tobias Langheinrich·Thibaud Lebouvier·Maria João Leitão·João Lemos·Marisa Lima·Albert Lladó·Gemma Lombardi·Jolina Lombardi
Abstract Frontotemporal dementia (FTD) is a neurodegenerative disease characterized by significant clinical and genetic heterogeneity, with approximately 40% of cases linked to hereditary genetic mutations, including MAPT , GRN , and C9ORF72 . Recently, microRNAs (miRNAs) have emerged as key regulators of cellular processes related to neurodegeneration and as potential biomarkers for FTD. However, their relevance in presymptomatic stages remains poorly understood. We conducted a miRNA expression